1 Buck ML, "Use of dexmedetomidine in the pediatric intensive care unit" 28 : 51-57, 2008
2 Mukhtar AM, "The use of dexmedetomidine in pediatric cardiac surgery" 103 : 52-56, 2006
3 Hall JE, "Sedative, amnestic, and analgesic properties of smalldose dexmedetomidine infusions" 90 : 699-705, 2000
4 Bejian S, "Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit" 19 : 98-104, 2009
5 Carmosino MJ, "Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization" 104 : 521-527, 2007
6 Bloor BC, "Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes" 77 : 1134-1142, 1992
7 Belleville JP, "Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate" 77 : 1125-1133, 1992
8 Shehabi Y, "Dexmedetomidine infusion for more than 24hours in critically ill patients: sedative and cardiovascular effects" 30 : 2188-2196, 2004
9 Nemoto S, "Dexmedetomidine enables not only optimal sedation but also minimizing life-threatening morbidities in intensive care management after pediatric cardiovascular surgery" 39 : 238-, 2011
10 Isik B, "Dexmedetomidine decreases emergence agitation in pediatric patients after sevoflurane anesthesia without surgery" 16 : 748-753, 2006
1 Buck ML, "Use of dexmedetomidine in the pediatric intensive care unit" 28 : 51-57, 2008
2 Mukhtar AM, "The use of dexmedetomidine in pediatric cardiac surgery" 103 : 52-56, 2006
3 Hall JE, "Sedative, amnestic, and analgesic properties of smalldose dexmedetomidine infusions" 90 : 699-705, 2000
4 Bejian S, "Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit" 19 : 98-104, 2009
5 Carmosino MJ, "Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization" 104 : 521-527, 2007
6 Bloor BC, "Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes" 77 : 1134-1142, 1992
7 Belleville JP, "Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate" 77 : 1125-1133, 1992
8 Shehabi Y, "Dexmedetomidine infusion for more than 24hours in critically ill patients: sedative and cardiovascular effects" 30 : 2188-2196, 2004
9 Nemoto S, "Dexmedetomidine enables not only optimal sedation but also minimizing life-threatening morbidities in intensive care management after pediatric cardiovascular surgery" 39 : 238-, 2011
10 Isik B, "Dexmedetomidine decreases emergence agitation in pediatric patients after sevoflurane anesthesia without surgery" 16 : 748-753, 2006